title: Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach.
abstract: We report a cirrhotic patient with complete occlusion of the portal vein with marked cavernous transformation due to chronic thrombosis in whom a transjugular intrahepatic portosystemic shunt (TIPS) was successfully created after direct minilaparotomy mesenteric vein catheterization, lysis and aspiration of the thrombus, and stenting in the portal vein. The methods used, we believe, provide a new technique for performing TIPS in chronically thrombosed portal veins in which previously no effective surgical therapeutic options were available.
authors.affiliation: Department of Radiology, Kanazawa University School of Medicine, 13-1 Takara-machi, Kanazawa 920, Japan.
authors.forename: O
authors.initials: O
authors.lastname: Matsui
authors.forename: J
authors.initials: J
authors.lastname: Yoshikawa
authors.forename: M
authors.initials: M
authors.lastname: Kadoya
authors.forename: T
authors.initials: T
authors.lastname: Gabata
authors.forename: T
authors.initials: T
authors.lastname: Takashima
authors.forename: T
authors.initials: T
authors.lastname: Urabe
authors.forename: M
authors.initials: M
authors.lastname: Unoura
authors.forename: K
authors.initials: K
authors.lastname: Kobayashi
mesh_terms: D000328:Adult; D000800:Angioplasty, Balloon; D002406:Catheterization, Peripheral; D002908:Chronic Disease; D006801:Humans; D007601:Jugular Veins; D007813:Laparotomy; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008642:Mesenteric Veins; D010960:Plasminogen Activators / Q000008:administration & dosage / Q000627:therapeutic use; D011169:Portal Vein / Q000473:pathology*; D019168:Portasystemic Shunt, Transjugular Intrahepatic / Q000379:methods*; D015607:Stents; D013396:Suction; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000188:drug therapy / Q000601:surgery* / Q000628:therapy; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator